Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Net Margin (2016 - 2025)

Jaguar Health (JAGX) has disclosed Net Margin for 11 consecutive years, with 234.97% as the latest value for Q3 2025.

  • On a quarterly basis, Net Margin fell 652.0% to 234.97% in Q3 2025 year-over-year; TTM through Sep 2025 was 261.83%, a 18427.0% increase, with the full-year FY2024 number at 329.3%, up 9381.0% from a year prior.
  • Net Margin was 234.97% for Q3 2025 at Jaguar Health, up from 268.28% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 143.2% in Q4 2024 to a low of 234683.33% in Q2 2021.
  • A 5-year average of 15196.98% and a median of 399.62% in 2022 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: crashed -23434873bps in 2021, then soared 23436266bps in 2022.
  • Jaguar Health's Net Margin stood at 688.12% in 2021, then surged by 66bps to 231.34% in 2022, then plummeted by -72bps to 398.7% in 2023, then surged by 64bps to 143.2% in 2024, then plummeted by -64bps to 234.97% in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Net Margin are 234.97% (Q3 2025), 268.28% (Q2 2025), and 478.59% (Q1 2025).